Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

Authors

• Jaanvi Mehta
• Julianna Tolotta
• Eleanor Matthews
• Daniel Joffe
• Safiyyah Bhatti
• Lauren Banner
• Jenna Mandel
• Molly Wallace
• Timothy Webster
• Jason B Lee
• Neda Nikbakht

Publication/Presentation Date

1-1-2026

Abstract

Langerhans cell histiocytosis (LCH) is a rare malignancy marked by clonal proliferation of Langerhans cells, with

Volume

2026

First Page

5004676

Last Page

5004676

ISSN

2090-6463

Published In/Presented At

Mehta, J., Tolotta, J., Matthews, E., Joffe, D., Bhatti, S., Banner, L., Mandel, J., Wallace, M., Webster, T., Lee, J. B., & Nikbakht, N. (2026). Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis. Case reports in dermatological medicine, 2026, 5004676. https://doi.org/10.1155/crdm/5004676

Disciplines

Medicine and Health Sciences

PubMedID

42460421

Department(s)

Department of Medicine

Document Type

Article